CLINICAL_TRIALS
research
· 2026-03-27
Clinical Trial Update: A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma [Phase 1]
Summary
A Phase 1 clinical trial evaluating the combination of glofitamab and lenalidomide in patients with mantle cell lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Mantle Cell Lymphoma, MCL | Phase 1 | Status: ACTIVE_NOT_RECRUITING